Blood Cancer

Explore treatment options for lymphoma, leukemia and multiple myeloma.

Why going to China for cancer treatment?

CAR T-cell Therapy

A breakthrough in blood cancer treatment.

0 %+
ORR in Multiple Myeloma
0 %+
ORR in Lymphoma
0 %+
ORR in Leukemia

Blood cancers, also known as hematological malignancies, are types of cancer that affect the blood, bone marrow, and lymphatic system. They arise from abnormal growth of blood cells or cells in the lymphatic system. These malignancies can be broadly categorized into three main types:

  1. Leukemia: Leukemia is a type of cancer that affects the blood and bone marrow, leading to an abnormal production of white blood cells. There are four main types of leukemia:

    • Acute lymphoblastic leukemia (ALL)
    • Acute myeloid leukemia (AML)
    • Chronic lymphocytic leukemia (CLL)
    • Chronic myeloid leukemia (CML)
  2. Lymphoma: Lymphoma is a cancer that originates in the lymphatic system, which is part of the body’s immune system. It affects lymphocytes, a type of white blood cell, and typically manifests as solid tumors in the lymph nodes. There are two main types of lymphoma:

    • Hodgkin lymphoma (HL)
    • Non-Hodgkin lymphoma (NHL)
  3. Multiple Myeloma: Multiple myeloma is a cancer of plasma cells, a type of white blood cell that produces antibodies. In multiple myeloma, abnormal plasma cells accumulate in the bone marrow and interfere with the production of normal blood cells.

These hematological malignancies can present with various symptoms, including fatigue, weakness, unexplained weight loss, fever, night sweats, enlarged lymph nodes, easy bruising or bleeding, bone pain, and recurrent infections. Diagnosis usually involves blood tests, bone marrow biopsy, imaging studies, and sometimes genetic testing.

Treatment options for hematological malignancies depend on the type and stage of cancer but may include chemotherapy, radiation therapy, targeted therapy, immunotherapy, stem cell transplantation, and supportive care measures to manage symptoms and complications.

Advancements in understanding the biology of these cancers and the development of targeted therapies and immunotherapies have improved treatment outcomes and survival rates for many patients with hematological malignancies. However, managing these cancers often requires a multidisciplinary approach involving hematologists, oncologists, radiation oncologists, and other healthcare professionals.

Symptoms of Blood Cancers

Some common symptoms associated with blood cancer are:

  • Fatigue: Persistent tiredness and weakness that doesn’t improve with rest.

  • Unexplained Weight Loss: Significant weight loss without any change in diet or exercise routine.

  • Fever: Frequent or persistent fever without any apparent cause or infection.

  • Night Sweats: Profuse sweating during the night, often soaking through clothing and bedding.

  • Frequent Infections: Increased susceptibility to infections due to a weakened immune system.

  • Easy Bruising or Bleeding: Unusual bruising or bleeding, such as frequent nosebleeds, bleeding gums, or prolonged bleeding from small cuts.

  • Enlarged Lymph Nodes: Swollen, painless lymph nodes in the neck, armpits, or groin.

  • Bone Pain or Tenderness: Pain in the bones, joints, or back, which may be severe and worsen at night.

  • Shortness of Breath: Difficulty breathing or shortness of breath, especially with minimal exertion.

  • Swelling of Abdomen or Spleen: Enlargement of the abdomen due to an enlarged spleen or liver.

  • Skin Changes: Red patches on the skin, easy bruising, or tiny red spots called petechiae.

  • Appetite Loss: Loss of appetite and a feeling of fullness even after eating small amounts of food.

Causes of Blood Cancers

Blood cancers, including leukemia, lymphoma, and myeloma, can arise from various factors, both genetic and environmental. Here are some causes and risk factors associated with these types of cancers:

  • Genetic Mutations: Changes in the DNA of blood cells can lead to uncontrolled growth and division, resulting in cancer. Some individuals inherit genetic mutations that predispose them to blood cancers, while others acquire mutations over time.
  • Family History: Having a close relative, such as a parent or sibling, with a history of blood cancer increases the risk of developing the disease. However, most cases of blood cancer occur in individuals without a family history of the condition.
  • Age: The risk of developing blood cancer increases with age. Most cases are diagnosed in older adults, although certain types of blood cancer, such as acute lymphoblastic leukemia (ALL), are more common in children and young adults.
  • Exposure to Ionizing Radiation: Prolonged exposure to ionizing radiation, such as from radiation therapy for previous cancers or occupational exposure, is a known risk factor for blood cancers.
  • Chemical Exposure: Exposure to certain chemicals, such as benzene (found in some industrial solvents and fuels), pesticides, and herbicides, may increase the risk of developing blood cancers.
  • Immune System Suppression: Conditions that weaken the immune system, such as HIV/AIDS or autoimmune diseases, or medications that suppress the immune system following organ transplantation, can increase the risk of blood cancers.
  • Viral Infections: Some viruses, such as the Epstein-Barr virus (EBV), human T-cell leukemia virus type 1 (HTLV-1), and human herpesvirus 8 (HHV-8), have been linked to the development of certain types of blood cancers.
  • Blood Disorders: Certain blood disorders, such as myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPNs), and autoimmune hemolytic anemia, can increase the risk of developing blood cancers.
  • Smoking and Tobacco Use: Smoking tobacco is associated with an increased risk of developing certain types of blood cancers, including acute myeloid leukemia (AML) and non-Hodgkin lymphoma.
  • Obesity: Some studies suggest that obesity may be associated with an increased risk of developing certain types of blood cancers, although more research is needed to understand this relationship fully.

How is blood cancer diagnosed?

Diagnosing blood cancer typically involves a combination of medical history review, physical examination, and various tests to confirm the presence of abnormal blood cells and determine the type and extent of the disease. Here’s an overview of the diagnostic process for blood cancer:

  • Medical History and Physical Examination: The healthcare provider will begin by taking a detailed medical history, including symptoms, risk factors, and family history of cancer. They will then conduct a physical examination to check for signs of enlarged lymph nodes, spleen, or liver, as well as other abnormalities.
  • Blood Tests: Blood tests are crucial for diagnosing blood cancer. These tests may include:
    • Complete Blood Count (CBC): This test measures the number of different types of blood cells, such as red blood cells, white blood cells, and platelets. Abnormalities in the blood cell counts may indicate the presence of blood cancer.
    • Peripheral Blood Smear: A small sample of blood is examined under a microscope to look for abnormal or immature blood cells.
    • Blood Chemistry Tests: These tests measure the levels of certain substances in the blood, such as electrolytes, kidney function markers, and liver enzymes, which can provide additional information about the overall health of the patient.
  • Bone Marrow Aspiration and Biopsy: If blood tests suggest the presence of blood cancer, a bone marrow aspiration and biopsy may be performed. During this procedure, a needle is used to extract a small sample of bone marrow (aspiration), usually from the hip bone, for examination under a microscope. A biopsy involves removing a small piece of bone and marrow tissue for further analysis.
  • Imaging Tests: Imaging tests, such as X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, or positron emission tomography (PET) scans, may be used to assess the extent of the disease, detect enlarged lymph nodes or organs, and identify any areas of bone involvement.
  • Genetic Tests: Genetic testing may be performed on blood or bone marrow samples to identify specific genetic mutations or chromosomal abnormalities associated with certain types of blood cancer. This information can help guide treatment decisions and prognosis.
  • Lymph Node Biopsy (if applicable): In cases where lymphoma is suspected, a biopsy of an enlarged lymph node may be performed to confirm the diagnosis and determine the type of lymphoma.

Once a diagnosis of blood cancer is confirmed, further tests may be conducted to determine the stage of the disease and develop an appropriate treatment plan. It’s important for individuals with symptoms suggestive of blood cancer to seek medical evaluation promptly for proper diagnosis and management.

Blood Cancer Treatment

The treatment of blood cancers, such as leukemia, lymphoma, and myeloma, typically depends on several factors, including the type of cancer, its stage, the patient’s overall health, and their preferences. Treatment may involve a combination of therapies aimed at eliminating cancer cells, controlling the disease, and relieving symptoms. Here are some common treatment options for blood cancers:

  • Chemotherapy: Chemotherapy involves the use of powerful drugs to kill cancer cells or stop their growth. It may be given orally or intravenously and is often used as the primary treatment for many types of blood cancers.
  • Targeted Therapy: Targeted therapy drugs specifically target cancer cells by interfering with specific molecules involved in cancer growth and progression. These drugs may have fewer side effects compared to chemotherapy and are often used in combination with other treatments.
  • Immunotherapy: Immunotherapy harnesses the body’s immune system to recognize and destroy cancer cells. This treatment approach may include monoclonal antibodies, checkpoint inhibitors, or adoptive cell therapy.
  • Stem Cell Transplantation: Stem cell transplantation, also known as bone marrow transplantation, involves replacing diseased or damaged bone marrow with healthy stem cells. This procedure may be used to treat certain types of leukemia, lymphoma, and myeloma, particularly in cases of high-risk disease or relapse.
  • Radiation Therapy: Radiation therapy uses high-energy beams of radiation to target and kill cancer cells. It may be used alone or in combination with other treatments to shrink tumors, relieve symptoms, or prepare for stem cell transplantation.
  • Surgery: Surgery may be performed in some cases to remove enlarged lymph nodes or to obtain a tissue sample for diagnosis (biopsy). However, surgery is less commonly used as a primary treatment for blood cancers compared to solid tumors.
  • Watchful Waiting or Active Surveillance: In some cases, especially for slow-growing or early-stage blood cancers, healthcare providers may recommend watchful waiting or active surveillance. This approach involves closely monitoring the disease without immediate treatment until it progresses or symptoms develop.
  • Supportive Care: Supportive care aims to manage symptoms, improve quality of life, and prevent complications associated with blood cancers and their treatments. This may include medications to manage pain, nausea, or infections, as well as nutritional support, counseling, and palliative care.

Treatment plans are often tailored to each individual patient’s specific circumstances, and treatment may change over time based on the response to therapy and disease progression. It’s essential for patients to work closely with a multidisciplinary healthcare team, including oncologists, hematologists, nurses, and other specialists, to develop a comprehensive treatment plan that meets their needs and preferences.

Survival Rates of Blood Cancers

The survival rates for blood cancers can vary widely depending on factors such as the type and stage of cancer, the age and overall health of the patient, and the effectiveness of treatment. Here are some general survival rate estimates for common types of blood cancers:

  • Leukemia:
    • Acute Lymphoblastic Leukemia (ALL): The overall 5-year survival rate for adults with ALL is around 40% to 50%. However, survival rates can be higher for children, with some estimates ranging from 85% to 90%.
    • Acute Myeloid Leukemia (AML): The overall 5-year survival rate for adults with AML is approximately 30% to 40%. Survival rates may vary depending on factors such as age, genetic mutations, and response to treatment.
  • Lymphoma:
    • Hodgkin Lymphoma: The overall 5-year survival rate for Hodgkin lymphoma is around 87%. Survival rates may vary depending on factors such as stage at diagnosis, age, and response to treatment.
    • Non-Hodgkin Lymphoma (NHL): Survival rates for NHL vary widely depending on the subtype and stage of the disease. Overall, the 5-year survival rate for NHL is approximately 72%.
  • Myeloma:
    • Multiple Myeloma: The overall 5-year survival rate for multiple myeloma is around 54%. Survival rates may vary depending on factors such as age, stage of the disease, and response to treatment.

It’s important to note that survival rates are estimates based on data from large populations and may not accurately predict an individual’s prognosis. Additionally, advances in treatment options and supportive care have improved survival rates for many individuals with blood cancers in recent years.

Survival rates are typically expressed as the percentage of people who are alive at a certain point in time after diagnosis, such as 5 years. These rates are often stratified by factors such as age, stage of cancer, and other variables.

For accurate information about prognosis and treatment options, individuals should consult with their healthcare providers, who can provide personalized guidance based on their specific circumstances.

Care at Cancer Care China's Medical Centers

Our caring team of experts can help you with lung cancer-related health concerns.

Contact a specialist